| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/14/1999 | CN1213562A Medicine for preventing and treating brain apoplexy |
| 04/14/1999 | CN1213561A Medicine for treating brain apoplexy |
| 04/14/1999 | CN1042933C Benzoylguanidine, prepn. of same and application as pharmaceutical and pharmaceutical containing same |
| 04/13/1999 | CA2155236C Gas phase polymerization process |
| 04/13/1999 | CA2116562C Morphogen-induced modulation of inflammatory response |
| 04/13/1999 | CA2044491C Novel process for industrial preparation of 4-chloro-3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol -1-yl) benzamide |
| 04/13/1999 | CA2044186C Novel process for industrial preparation of 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide from 2,3-dihydro 2-methyl 1h-indole and hydroxylamine-0-sulfonic acid |
| 04/13/1999 | CA2005547C Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016889A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | WO1999016753A2 Tricyclic 3-oxo-propanenitrile compounds |
| 04/08/1999 | WO1999016751A1 Benzamidine derivatives as factor xa inhibitors |
| 04/08/1999 | WO1999016750A1 Thrombin inhibitors |
| 04/08/1999 | WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | WO1999016741A2 Lipophilic diesters of chelating agents |
| 04/08/1999 | WO1999016459A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016458A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016445A1 Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 04/08/1999 | WO1999016444A1 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 04/08/1999 | WO1999016443A1 Oral compositions of levosimendan |
| 04/08/1999 | WO1999016437A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 04/08/1999 | WO1999016409A2 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016408A2 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016375A1 Method of treating the syndrome of coronary heart disease risk factors in humans |
| 04/08/1999 | WO1999010322B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 04/08/1999 | WO1999003508A3 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 04/08/1999 | WO1998056913A9 Smad6 and uses thereof |
| 04/08/1999 | WO1998055638A9 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
| 04/08/1999 | WO1998052549A3 Use of fumaric acid derivatives |
| 04/08/1999 | DE19743435A1 Benzamidinderivate Benzamidine derivatives |
| 04/08/1999 | CA2305568A1 Benzamidinderivates |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2305017A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | CA2304931A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304827A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | CA2304814A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304805A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2303832A1 Thrombin inhibitors |
| 04/08/1999 | CA2303401A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | CA2302025A1 Tricyclic 3-oxo-propanenitrile compounds |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/07/1999 | EP0906957A2 Lgt polypeptide |
| 04/07/1999 | EP0906911A1 Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them |
| 04/07/1999 | EP0906421A1 Enhanced efficacy of liposomal antisense delivery |
| 04/07/1999 | EP0906307A1 Substituted imidazoles having cytokine inhibitory activity |
| 04/07/1999 | EP0906303A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/07/1999 | EP0906276A1 Novel vitamin d analogues |
| 04/07/1999 | EP0906268A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 04/07/1999 | EP0906123A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 04/07/1999 | EP0906121A1 Vasoactive effects and free radical generation by beta-amyloid peptides |
| 04/07/1999 | EP0906117A1 Method for treating or preventing ischemia-reperfusion injury |
| 04/07/1999 | EP0906108A1 Method of treating heart failure with endothelin antagonists |
| 04/07/1999 | EP0906103A1 Vitronectin receptor antagonists |
| 04/07/1999 | EP0906102A1 A process for regulating vagal tone |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0781268B1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 04/07/1999 | EP0770059B1 Substituted benzamidines, their production and their use as medicaments |
| 04/07/1999 | EP0669824B1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| 04/07/1999 | EP0647266B1 D-enzyme compositions and methods of their use |
| 04/07/1999 | EP0632033B1 Novel benzopyran derivative |
| 04/07/1999 | CN1213372A Heterocycle-condensed morphinoid derivatives (II) |
| 04/07/1999 | CN1213370A Substituted sulfonic acid N-[(aminoiminomethyl) phenylalkyl]-azaheterocyclamide compounds |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213306A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213305A Novel cycloalkyl substituted imidazolium compounds |
| 04/07/1999 | CN1213304A Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives ad NMDA receptor subtype blockers |
| 04/07/1999 | CN1212964A Sulfonic acid amide substituted benzodihydropyrane processes for their preparation, their use as medicament and pharmaceutical preparations comprising them |
| 04/07/1999 | CN1212885A Traditional Chinese medicine capsule for treating thrombophlebitis |
| 04/07/1999 | CN1212881A Method for preparing fermented soya beans and ginger injecta |
| 04/07/1999 | CN1212869A Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/06/1999 | US5892114 Hetero-linked phenylglycinolamides |
| 04/06/1999 | US5892045 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 04/06/1999 | US5892039 Piperazino derivatives as neurokinin antagonists |
| 04/06/1999 | US5891900 Oxopyrolo-pyrrole derivatives having thrombin inhibiting activity |
| 04/06/1999 | US5891894 2-amino oxazole derivatives; antagonists of platelet activating factor useful in treatment of asthma, inflammation, cardiovascular disorders, renal diseases, or as contraceptives |
| 04/06/1999 | US5891893 5-amino-1,2,4-oxa(or thia)diazoles; antagonists of platelet activating factor useful in treatment of asthma, allergies, inflammation, cardiovascular diseases, renal diseases, or as contraceptives |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891852 Serine protease inhibitors-cycloheptane derivatives |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891655 Screening low molecular weight compounds for modulation of fibroblast growth factor activity such as mitogenesis of receptor expressing cells as well as competitive binding with heparin to receptor and dimerization |
| 04/06/1999 | CA2135070C Use of guanylate cyclase inhibitors in the treatment of shock |
| 04/06/1999 | CA2024700C Benzoylguanidines, a process for their preaparation, their use as medicaments and medicaments containing them |
| 04/06/1999 | CA2000804C Quinolyloxazole-2-ones useful as proteinkinase c inhibitors |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/06/1999 | CA1340479C Indane derivatives, process for preparing the same, new intermediates produced, use thereof as therapeutic agents and pharmaceutical compositions containing them |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015548A2 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
| 04/01/1999 | WO1999015530A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 04/01/1999 | WO1999015526A2 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives |
| 04/01/1999 | WO1999015523A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 04/01/1999 | WO1999015508A1 Vitronectin receptor antagonists |
| 04/01/1999 | WO1999015504A1 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein |
| 04/01/1999 | WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/1999 | WO1999015498A1 New npy antagonists |
| 04/01/1999 | WO1999015494A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |